If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
substantiate the benefit of optimal medical therapy (OMT) on long-term survival after surgical coronary revascularization in patients suffering from ischemic cardiomyopathy. This finding is particularly important given the surprisingly low adherence to OMT and attenuated long-term survival rates in these high-risk patients.
At face value, the authors' conclusion that OMT significantly improves long-term outcomes in these patients is intuitive, given that similar evidence-based medical regimens, including antiplatelet, beta-blocker, and lipid-lowering agents have long been shown to similarly benefit patients without heart failure undergoing coronary artery revascularization via surgical or percutaneous interventions. More importantly, the study shines a spotlight on the potentially greater overall impact of increasing adherence to OMT regimens, prompting better characterization of the multifactorial causes behind noncompliance and the development of effective remedial strategies.
Recent studies have investigated OMT noncompliance from different perspectives. Mathews and colleagues
reported that among patients hospitalized for acute myocardial infarction, commercial health insurance, prescription coverage insurance, and outpatient follow-up were associated with increased compliance, whereas increasing age, black race, and depression were negative markers of compliance. Diaz-Toro and colleagues
identified socioeconomic status as a powerful independent predictor of chronic heart failure and adverse outcomes, with inequities directly influencing the management and prognoses of these patients. Finally, Kurlansky and colleagues
astutely noted that even with the benefit of protocolized monitoring among clinical trial participants, suboptimal adherence to prescribed medical regimens (in the 43% to 78% range) has been reported among patients receiving treatment for chronic conditions (eg, heart failure).
Farsky and colleagues demonstrate a prevalence of OMT that was significantly higher than reported in other contemporary randomized and observational trials of coronary artery bypass patients. Achieving 73.3% prevalence of OMT over the first 4 months of the trial resulted in more durable medical compliance among these chronic heart failure patients, at least for the first 5 years, translating into lower all-cause mortality over the study period irrespective of surgical treatment. This suggests that active medical optimization combined with regularly scheduled clinical assessments are effective measures in prolonging survival and improving quality of life in these patients.
Parenthetically, it is interesting to note higher baseline percentages of patients in the New York Heart Association (NYHA) heart failure class I/class II and CCS class I categories among OMT patients compared with non-OMT patients. Although this might be attributed to random chance, it might be postulated that NYHA class I and class II patients in the OMT group were less physically limited by heart failure symptoms and thus able to exert themselves more to the point of experiencing mild exertional angina.
Farsky and colleagues' findings set the stage for further investigation of the intermediate- and long-term consequences of OMT on patients suffering from ischemic cardiomyopathy. Additional questions could include characterizing the relative impact of the different components of OMT on outcomes and more robust definition of the impact of OMT on long-term survival within each of the NYHA and CCS functional categories.
Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy.
Disclosures: The author reported no conflicts of interest.
The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.
Optimal medical therapy in patients with heart failure and coronary artery disease is associated with improved outcomes. However, whether this association is influenced by the performance of coronary artery bypass grafting is less well established. Thus, the aim of this study was to determine the possible relationship between coronary artery bypass grafting and optimal medical therapy and its effect on the outcomes of patients with ischemic cardiomyopathy.